Retatrutide 20mg

Next-Generation Triple Agonist Peptide for Advanced Metabolic Research

Retatrutide 20mg is a high-purity, research-grade peptide being studied for its potential effects on weight management, glucose regulation, energy expenditure, and overall metabolic health. Unlike traditional GLP–1 receptor agonists, Retatrutide is a triple hormone receptor agonist that activates GIP (Glucose-Dependent Insulinotropic Polypeptide), GLP-1 (Glucagon-Like Peptide-1), and glucagon receptors. This unique three-receptor mechanism has made it one of the most promising investigational peptides in obesity and metabolic research.The 20mg formulation provides a higher peptide content for extended laboratory research protocols while maintaining exceptional purity, stability, and consistency.

Product Highlights

• Peptide: Retatrutide (LY3437943)
• Strength: 20mg per vial
• Category: Triple GIP, GLP-1 & Glucagon Receptor Agonist
• Form: Lyophilized (freeze-dried) peptide powder
• Administration: Reconstituted for subcutaneous injection in research settings
• Quality: High-purity research-grade peptide

What Is Retatrutide Made Of?

Retatrutide is a synthetic 39-amino acid peptide engineered to simultaneously activate the body’s GIP, GLP-1, and glucagon receptors. Structural modifications enhance its stability and prolong its activity, supporting once-weekly administration in clinical research protocols.

What Is Retatrutide Studied For?

Retatrutide is currently being investigated for its potential role in:

• Supporting healthy weight management
• Improving blood glucose regulation
• Enhancing insulin sensitivity
• Reducing appetite and food intake
• Increasing feelings of fullness (satiety)
• Increasing energy expenditure
• Supporting fat metabolism and fat oxidation
• Improving overall metabolic health
• Investigating obesity, type 2 diabetes, and related metabolic disorders

Clinical studies have demonstrated significant weight–loss and metabolic improvements, while ongoing Phase 3 trials continue to evaluate its long-term safety and effectiveness.

Potential Benefits

• Supports metabolic and obesity research
• May promote healthy body weight
• May reduce appetite and food cravings
• Supports healthy blood glucose metabolism
• May increase calorie expenditure
• High-purity peptide for laboratory research
• Designed for convenient once-weekly administration in clinical trials

How It Works

Retatrutide activates three key metabolic hormone receptors:

• GLP-1 receptors to promote satiety, suppress appetite, and slow gastric emptying.
• GIP receptors to support glucose-dependent insulin secretion and improve metabolic function.
• Glucagon receptors to increase energy expenditure and enhance fat utilization.

The combined activation of these three pathways is being studied for potentially greater effects on weight management and metabolic health than therapies targeting only one or two receptors.

Storage

• Store the unopened lyophilized vial in a cool, dry place.
• After reconstitution, refrigerate according to laboratory protocol.
• Protect from excessive heat, moisture, and direct light.
• Do not use if the solution becomes cloudy or contains particulate matter.